Related Experiment Video
Updated: Oct 14, 2025

Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
[Dermatological manifestations of monoclonal gammopathies]
Rodrigo Meza-Romero1, Romina Andino1, Patricio Rojas2
1Departamento de Dermatología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
Abstract:
Monoclonal gammopathies of uncertain significance (MGUS) correspond to pre-malignant hematological disorders characterized by the production of a monoclonal protein and infiltration of less than 10% of the bone marrow by plasma cells. Its importance lies in the risk of progression to malignant disorders and in the association with different renal, neurological and skin manifestations. There are pathophysiological mechanisms that support a causal relationship between monoclonal gammopathies (MGs) and different skin diseases, such as type I cryoglobulinemia (CG), primary systemic amyloidosis (PSA) or necrobiotic xanthogranuloma (NXG). However, there is a group of skin diseases associated with MGs whose pathogenesis has not been elucidated. In this context, the role of the dermatologist is crucial in the suspicion of different haematological disorders based on skin manifestations and in the multidisciplinary treatment of these patients. In this article, we carry out an exhaustive review of the literature published in this area and propose a screening algorithm for MGs in patients with specific skin diseases.
Insights
Monoclonal gammopathies of uncertain significance (MGUS) are pre-malignant conditions linked to skin issues. Dermatologists play a key role in identifying these hematological disorders through skin manifestations.
Area of Science:
- Hematology
- Dermatology
- Oncology
Background:
- Monoclonal gammopathies of uncertain significance (MGUS) are pre-malignant hematological disorders.
- MGUS involves monoclonal protein production and <10% bone marrow plasma cell infiltration.
- MGUS carries risks of malignant progression and associations with renal, neurological, and skin conditions.
Purpose of the Study:
- To review the literature on the relationship between monoclonal gammopathies (MGs) and skin diseases.
- To elucidate the pathophysiological mechanisms linking MGs and specific skin manifestations.
- To propose a screening algorithm for MGs in patients with particular dermatological conditions.
Main Methods:
- Exhaustive literature review on MGUS and associated skin diseases.
- Analysis of pathophysiological mechanisms supporting causal relationships.
- Development of a diagnostic screening algorithm for MGs based on dermatological findings.
Main Results:
- Established causal links between MGs and skin diseases like cryoglobulinemia, amyloidosis, and xanthogranuloma.
- Identified a subset of skin diseases with unclear pathogenesis linked to MGs.
- Highlighted the critical role of dermatologists in early detection and multidisciplinary management.
Conclusions:
- Dermatologists are essential in suspecting hematological disorders based on skin signs.
- A multidisciplinary approach is vital for managing patients with MGUS and skin manifestations.
- The proposed screening algorithm aims to improve early diagnosis of MGs in at-risk patients.
Related Concept Videos
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Chronic Kidney Disease II: Clinical Manifestations
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Nephrotic Syndrome I : Introduction
Endocarditis II: Clinical Features of Infective Endocarditis

